Stock Market

Herbalife misses profit estimates, share price plunges

Herbalife misses profit estimates, share price plunges

By Hank Schultz

Herbalife's share price dropped sharply yesterday as the company reported second quarter earnings that missed analysts’ estimates.  Shares dropped 11% almost immediately on the news and declined further in early trading today, with a share price...

Neptune notches loss as it strives to maintain market share

Neptune notches loss as it strives to maintain market share

By Hank Schultz

Neptune Technologies and Bioressources, the pioneer in the krill oil sector, has reported a second quarter loss as it recovers from the destruction of its sole production facility.  The company will have some work to do to regain market share once it...

Neptune slapped with two more shareholders' rights lawsuits

Neptune slapped with two more shareholders' rights lawsuits

By Hank Schultz

Krill oil producer Neptune Technologies and Bioressources has been slapped with two additional class action shareholders’ rights lawsuits and another two law firms have announced investigations into whether the company has violated securities laws.

Neptune hit with shareholders' rights lawsuit

Neptune hit with shareholders' rights lawsuit

By Hank Schultz

Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.

DuPont succeeds in Danisco bid

DuPont succeeds in Danisco bid

By Caroline Scott-Thomas

US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.

DSM reports successful tender offer for Martek

DSM reports successful tender offer for Martek

By Mike Stones

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...

Investors eye Bunge?

Investors eye Bunge?

Two years after the company went public, $20 billion US oilseed
giant Bunge declares a regular quarterly cash dividend of $0.11 per
share following swiftly on from strong second quarter earnings
announced in July this year.

Aventis sells Rhodia stake

Aventis sells Rhodia stake

Franco-German pharmaceuticals company Aventis continues the
divestment of French speciality chemicals company Rhodia with the
announcement on Tuesday that it has reduced its stake from 25.2 per
cent to 15.3 per cent by selling 17.8...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All